These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9114979)
1. Cytochrome P4502C11 is a target of diclofenac covalent binding in rats. Shen S; Hargus SJ; Martin BM; Pohl LR Chem Res Toxicol; 1997 Apr; 10(4):420-3. PubMed ID: 9114979 [TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac. Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801 [TBL] [Abstract][Full Text] [Related]
3. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798 [TBL] [Abstract][Full Text] [Related]
4. Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites. Tang W; Stearns RA; Bandiera SM; Zhang Y; Raab C; Braun MP; Dean DC; Pang J; Leung KH; Doss GA; Strauss JR; Kwei GY; Rushmore TH; Chiu SH; Baillie TA Drug Metab Dispos; 1999 Mar; 27(3):365-72. PubMed ID: 10064567 [TBL] [Abstract][Full Text] [Related]
5. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity. Tang C; Shou M; Rodrigues AD Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636 [TBL] [Abstract][Full Text] [Related]
6. Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds. Bonierbale E; Valadon P; Pons C; Desfosses B; Dansette PM; Mansuy D Chem Res Toxicol; 1999 Mar; 12(3):286-96. PubMed ID: 10077492 [TBL] [Abstract][Full Text] [Related]
7. Mechanism-based inactivation of CYP2C11 by diclofenac. Masubuchi Y; Ose A; Horie T Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726 [TBL] [Abstract][Full Text] [Related]
8. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate. Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177 [TBL] [Abstract][Full Text] [Related]
9. Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis. Kretz-Rommel A; Boelsterli UA Mol Pharmacol; 1994 Feb; 45(2):237-44. PubMed ID: 8114673 [TBL] [Abstract][Full Text] [Related]
10. Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes. Narimatsu S; Tachibana M; Masubuchi Y; Suzuki T Chem Res Toxicol; 1996; 9(1):93-8. PubMed ID: 8924622 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct. Kretz-Rommel A; Boelsterli UA Drug Metab Dispos; 1994; 22(6):956-61. PubMed ID: 7895615 [TBL] [Abstract][Full Text] [Related]
12. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase. Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305 [TBL] [Abstract][Full Text] [Related]
13. Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase. Morgan ET; MacGeoch C; Gustafsson JA Mol Pharmacol; 1985 Apr; 27(4):471-9. PubMed ID: 3982392 [TBL] [Abstract][Full Text] [Related]
14. The substrate binding site of human liver cytochrome P450 2C9: an NMR study. Poli-Scaife S; Attias R; Dansette PM; Mansuy D Biochemistry; 1997 Oct; 36(42):12672-82. PubMed ID: 9335524 [TBL] [Abstract][Full Text] [Related]
15. Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase. Draper AJ; Hammock BD Arch Biochem Biophys; 2000 Apr; 376(1):199-205. PubMed ID: 10729206 [TBL] [Abstract][Full Text] [Related]
16. In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (+/-)-fluvastatin. Transon C; Leemann T; Vogt N; Dayer P Clin Pharmacol Ther; 1995 Oct; 58(4):412-7. PubMed ID: 7586933 [TBL] [Abstract][Full Text] [Related]
17. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor. Venkatakrishnan K; von Moltke LL; Greenblatt DJ Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170 [No Abstract] [Full Text] [Related]
18. [Diminished activity of testosterone-16-alpha hydroxylase in bovine liver microsomes]. Depelchin BO Ann Rech Vet; 1984; 15(4):515-8. PubMed ID: 6529121 [TBL] [Abstract][Full Text] [Related]
19. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides. Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831 [TBL] [Abstract][Full Text] [Related]
20. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation. Munns AJ; De Voss JJ; Hooper WD; Dickinson RG; Gillam EM Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]